Disease specific therapies in leukodystrophies and leukoencephalopathies. - Wikidata - awgldk - TriplyDB

Disease specific therapies in leukodystrophies and leukoencephalopathies.

Disease specific therapies in leukodystrophies and leukoencephalopathies.

http://www.wikidata.org/entity/Q35328494

about

How to make an oligodendrocyte Gene therapy for metachromatic leukodystrophy.Glial progenitor cell-based treatment of the childhood leukodystrophies.Hypomyelinating leukodystrophies - a molecular insight into the white matter pathology.Modeling the Mutational and Phenotypic Landscapes of Pelizaeus-Merzbacher Disease with Human iPSC-Derived Oligodendrocytes.Participant-driven matchmaking in the genomic era.Evidence for improved survival in postsymptomatic stem cell-transplanted patients with Krabbe's disease.Ulk4 deficiency leads to hypomyelination in mice.

P2860

Q26775534-D46ED4E7-E57D-4AA0-BAD7-E9BF9D289410 Q30357745-7C401BCE-24FF-4043-9317-8C61537CC620 Q37684345-112A29B0-07DE-4BAA-AD99-0693469DBC1F Q38846368-01D96C7F-DF19-4813-9240-D8C90CEC4CAE Q38862033-14D6F6CC-197D-4DC0-9A32-A807039A0C22 Q40648775-17A8D57A-4E84-4804-B604-F296F69E8673 Q41042792-D7A7F778-8FBA-4760-BCB2-D1E4ECBEAE41 Q47442451-776673F0-691F-4BE5-BB7A-05BCAAF7D19C

P2860

Disease specific therapies in leukodystrophies and leukoencephalopathies.

http://www.wikidata.org/entity/Q35328494

description

2015 nî lūn-bûn

@nan

2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Disease specific therapies in leukodystrophies and leukoencephalopathies.

@ast

Disease specific therapies in leukodystrophies and leukoencephalopathies.

@en

type

label

Disease specific therapies in leukodystrophies and leukoencephalopathies.

@ast

Disease specific therapies in leukodystrophies and leukoencephalopathies.

@en

prefLabel

Disease specific therapies in leukodystrophies and leukoencephalopathies.

@ast

Disease specific therapies in leukodystrophies and leukoencephalopathies.

@en

P1433

Q35328494-05637820-6739-4922-8C7C-1577C95E989C

P1476

Q35328494-5915A1D0-2382-44F4-AE19-6EDE5A28F418

P2093

Q35328494-020665A8-8CB1-4FF8-860B-50F827BC5F8C

Q35328494-07D195C7-FDBF-4C22-91B3-9058B6069EFF

Q35328494-0A444FB9-BB6C-441F-8B10-44E948957EEE

Q35328494-2680A699-D330-4A15-B0D1-2D0840B81F73

Q35328494-38AE5FD4-17D4-4B24-BE17-88DCB6FA4397

Q35328494-393C9847-8EE5-44B0-8BC2-446298B8CE54

Q35328494-4108E339-0410-4B77-8E71-4F76280D17A7

Q35328494-867670A2-9C1D-410B-8E21-86D71E08C02A

Q35328494-8D4F4646-8CD9-4624-8A5D-1D75D280B480

Q35328494-982AE8BA-92AC-44FD-8564-229254E5CC5F

P2860

Q35328494-00059F5E-7D6E-49A0-B4D5-E1EA8A330789

Q35328494-15FDA6A6-EF6B-4623-A102-C3BA48352754

Q35328494-17F4C26C-9297-4185-877F-2B7AB209ACA5

Q35328494-199E14E8-7B83-44F3-96EE-58FBF3D78DF4

Q35328494-19A00EDD-1531-45DF-B794-BADCA6A13C30

Q35328494-21D1DF8A-FC4C-4AE1-B825-D2F204C0DEE9

Q35328494-26669BB9-E7AF-4CAF-9F1F-27C52A6C4E7B

Q35328494-27E2C670-E3B6-442B-8A71-6F4F4C1F665A

Q35328494-28CC84CA-70DB-40E9-9C51-D27798E1D560

Q35328494-2BFD609E-2202-47DE-BF8C-ADA10DB374FE

P304

Q35328494-B22C126E-C2EF-45D9-B19E-9F5408E6171E

P31

Q35328494-8BD9F35B-1B2A-4AB2-8666-5DB7B0A41F62

P356

Q35328494-C9952B03-B7C3-44ED-B7BA-E76305C2E734

P433

Q35328494-2EAC004B-703E-4D0F-B4BF-A914A607DD86

P478

Q35328494-F0170E6B-14D4-4DFB-9F5C-236694553F50

P50

Q35328494-1618A02D-CA1A-4D85-85BF-5EBB58F9D321

Q35328494-9236C450-4901-4EA9-929A-20D6982FE3A4

Q35328494-B2A399A3-F070-4E95-9D18-12608AF91A39

Q35328494-BAD950DF-51DB-4CDC-A79A-3C8EC5214DB4

Q35328494-C9987503-F26B-4D35-BBF1-486C10CFD220

Q35328494-DDA6E5C4-1B82-4D73-85E3-D256AF118536

P577

Q35328494-3663A2DA-529A-4248-A238-02A735E8E6D2

P5875

Q35328494-80FD896C-FB36-4FD7-B5D6-3230812E74C0

P698

Q35328494-A769F0F6-F99C-42A8-BC41-5AB5162A91AC

P932

Q35328494-A8092D3D-4E8B-4BC2-842F-5A17BB0091B1

P356

J.YMGME.2015.01.014

P1433

Molecular Genetics and Metabolism

P1476

Disease specific therapies in leukodystrophies and leukoencephalopathies.

@en

P2093

Albee Messing

http://www.w3.org/2001/XMLSchema#string

Amy Pizzino

http://www.w3.org/2001/XMLSchema#string

Asako Takanohashi

http://www.w3.org/2001/XMLSchema#string

Dean Suhr

http://www.w3.org/2001/XMLSchema#string

Florian Eichler

http://www.w3.org/2001/XMLSchema#string

GLIA Consortium

http://www.w3.org/2001/XMLSchema#string

Jeff Leonard

http://www.w3.org/2001/XMLSchema#string

Joshua L Bonkowsky

http://www.w3.org/2001/XMLSchema#string

Lawrence Wrabetz

http://www.w3.org/2001/XMLSchema#string

Magdalena Petryniak

http://www.w3.org/2001/XMLSchema#string

P2860

Mutations involved in Aicardi-Goutières syndrome implicate SAMHD1 as regulator of the innate immune response

Trex1 prevents cell-intrinsic initiation of autoimmunity

Identification of a common PEX1 mutation in Zellweger syndrome

PEX1 mutations in complementation group 1 of Zellweger spectrum patients correlate with severity of disease

Transplantation of umbilical-cord blood in babies with infantile Krabbe's disease

Molecular genetics of Krabbe disease (globoid cell leukodystrophy): diagnostic and clinical implications

Mutations in the gene encoding the 3'-5' DNA exonuclease TREX1 cause Aicardi-Goutières syndrome at the AGS1 locus

Long-term treatment of cerebrotendinous xanthomatosis with chenodeoxycholic acid

Mutations in ADAR1 cause Aicardi-Goutières syndrome associated with a type I interferon signature

Enzyme, cell and gene-based therapies for metachromatic leukodystrophy

P304

527-536

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.YMGME.2015.01.014

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

114

http://www.w3.org/2001/XMLSchema#string

P50

Marc C. Patterson

Adeline Vanderver

David H Rowitch

Geneviève Bernard

Keith van Haren

P577

2015-02-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

272358415

http://www.w3.org/2001/XMLSchema#string

P698

25684057

http://www.w3.org/2001/XMLSchema#string

P932

4390468

http://www.w3.org/2001/XMLSchema#string